Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Role of HLA Evolutionary Divergence in Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Association between HLA evolutionary divergence and leukemia relapse after allogeneic SCT from 10/10 HLA matched related/unrelated donor

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Graft Engineering for allogeneic hematopoietic stem cell transplantation (HSCT) and modified donor lymphocyte infusion (DLI)

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Moniek de Witte

Intrabone infusion of a single umbilical cord blood unit in adults with hematological disease: a Eurocord, CTIWP-EBMT Analysis

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Jacopo Peccatori

CAR-T Data Collection Initiative

Post Authorization Safety (PAS) Studies

Acute Lymphatic Leukaemia (ALL)

Non-Hodgkin’s Lymphoma (NHL)

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal